IDPH Reports 26 Illinois Counties at an Elevated Community Level for COVID-19
IDPH has recorded a total of 4,083,292 cases and 36,431 deaths, in 102 counties in Illinois since the beginning of the pandemic. The department is reporting 10,320 new confirmed and probable cases of COVID-19 in Illinois in the week ending March 5, and 45 deaths.
IDPH Director Dr. Sameer Vohra warned that cases of group A strep throat leading to severe complications are on the rise in Illinois, with more cases reported in 2023 than in any of the past five years.
"As COVID-19 cases and community levels remain stable, I want to share my concern about the growing number of strep throat cases in Illinois that are leading to severe complications," Director Vohra said. "These cases, known as invasive Group A strep, are the result of disease spreading from the throat to blood, muscle and lungs. I urge parents to contact their health providers when their children start showing early symptoms. These symptoms include sudden onset of sore throat, pain when swallowing and fever. Early detection is critical as strep can be diagnosed with a simple test and treated with antibiotics. If able, please make sure everyone in the house is up to date with flu and chickenpox vaccines. Having either the flu or chickenpox can increase your risk of contracting invasive Group A strep."
IDPH is helping Illinoisans stay prepared for any future surge of COVID-19 cases by offering 1 million free COVID-19 rapid antigen tests to Illinois residents in all zip codes outside the City of Chicago through a partnership with the Rockefeller Foundation's public charity, RF Catalytic Capital and its Project ACT (Access COVID Tests) program.
The CDC authorized two new bivalent booster vaccines on September 1 that include an mRNA component of the original strain to provide an immune response that is broadly protective against COVID-19 and an added mRNA component in common between the omicron variant BA.4 and BA.5 lineages to provide better protection against COVID-19 caused by the omicron variant.
Initially, the Moderna COVID-19 Vaccine, Bivalent, was authorized for use as a single booster dose in individuals 18 years of age and older and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent, was authorized for use as a single booster dose in individuals 12 years of age and older. On October 12, the CDC authorized the updated COVID-19 vaccines from Pfizer-BioNTech for children ages 5 through 11 years, and from Moderna for children and adolescents ages 6 through 17 years.
On December 9, the CDC expanded its authorization for bivalent boosters to include children aged 6 months to 5 years. Children ages 6 months through 5 years who previously completed a Moderna primary series can now receive a Moderna bivalent booster 2 months after their final primary series dose. Children ages 6 months through 4 years who are completing a Pfizer primary series will receive a Pfizer bivalent vaccine as their third primary dose.
As of last night, 880 individuals in Illinois were reported to be in the hospital with COVID-19. Of those, 102 patients were in the ICU and 33 patients with COVID-19 were on ventilators. The preliminary seven-day statewide case rate is 81 COVID-19 cases per 100,000 Illinoisans.
In counties at the Medium Community Level, persons who are elderly or immunocompromised (at risk of severe outcomes) are advised to wear a mask in indoor public places. They should also get up to date on COVID-19 vaccines or get their bivalent booster, if eligible.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
